文献速递产科母胎医学

从危险到新现实:科学进展改变孕前糖尿病妊娠管理与结局

From peril to new reality: scientific advances transform pregestational diabetes in pregnancy care and outcomes.
PubMed 文献 · Am J Obstet Gynecol · 2026-07-14

本文回顾了孕前糖尿病从极端热量限制时代(孕产妇死亡率超过50%)到胰岛素发现后妊娠成为可能,再到现代血糖监测与自动胰岛素输注系统改善母胎结局的历程。高血糖作为致畸原的发现凸显了孕前保健的重要性,但先兆子痫、早产、大于胎龄儿等风险仍存,全球范围内孕前保健和糖尿病技术可及性差异仍是主要障碍。

要点

  • 高血糖是致畸原,血糖水平是可干预的先天畸形风险因素,孕前保健至关重要。
  • 连续血糖监测和自动胰岛素输注系统改善孕期血糖稳定性,降低大于胎龄儿、新生儿重症监护入住和新生儿低血糖发生率。
  • 先兆子痫、早产、大于胎龄儿、先天畸形、剖宫产等风险仍存在,孕前保健和技术可及性差异是全球主要障碍。

核心结论

  • 科学发现与临床进步已显著改善孕前糖尿病妊娠结局,但多项母胎风险仍持续存在。
  • 孕前保健和糖尿病技术的全球可及性差异是实现最佳结局的主要障碍。

研究设计与样本

  • 本文为综述,回顾塑造孕前糖尿病妊娠现代管理的科学发现与临床进展。

主要发现

  • 历史上孕前糖尿病孕产妇死亡率超过50%,胰岛素发现后妊娠成为可能但母胎并发症发生率高。
  • 高血糖作为致畸原的发现使血糖成为可干预的先天畸形风险因素。
  • 胎儿超声和超声心动图进步直接改善了新生儿护理并降低围产期死亡率。
  • 连续血糖监测和自动胰岛素输注系统改善 maternal 血糖稳定性,降低大于胎龄儿、新生儿重症监护入住和新生儿低血糖发生率。
  • 先兆子痫、早产、大于胎龄儿、先天畸形、剖宫产、新生儿并发症及子代长期健康后果等风险仍存在。

临床怎么用

  • 应将孕前保健作为孕前糖尿病管理的核心环节,强调血糖控制以降低先天畸形风险。
  • 可利用连续血糖监测和自动胰岛素输注系统改善孕期血糖稳定性并降低新生儿不良结局。
  • 需持续关注并管理先兆子痫、早产、大于胎龄儿、剖宫产等持续存在的风险。

局限性

  • 本文为综述,未报告原始研究的设计细节、样本量或定量合并结果。
  • 全球孕前保健和糖尿病技术可及性差异仍是主要障碍,可能限制结论的普遍适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For hundreds of years, pregestational diabetes mellitus was a life-limiting, devastating diagnosis managed by extreme caloric restriction, but with the inevitable outcome of wasting and death within months to a few years. The maternal mortality rate was unacceptably high (over 50%), and although many women desired to have children, or even the chance despite the extremely high rates of pregnancy loss, fetal death, and neonatal death, women were universally discouraged from pregnancy due to high maternal risk. This was accompanied by depression and even suicide in some instances. When insulin was discovered in 1921, pregnancy became possible but associated with high maternal and perinatal morbidity and mortality. Over the past several decades, remarkable discoveries in the pathophysiology of diabetes and innovations in management have been made. The discovery of hyperglycemia as a teratogen, and thus blood glucose levels as a modifiable risk factor for congenital anomalies, has highlighted the importance of preconception care. Advances in fetal ultrasound and echocardiography have led directly to improved neonatal care and a reduction in perinatal mortality. Continuous glucose monitoring and automated insulin delivery systems have improved maternal glycemic stability, subsequently decreasing rates of large for gestational age infants, neonatal intensive care unit admissions, and neonatal hypoglycemia. However, risks remain, including preeclampsia, preterm birth, large for gestational age infants, congenital anomalies, cesarean delivery, neonatal morbidity, and long-term offspring health consequences. While ongoing advances in prenatal imaging and screening protocols continue to improve diagnosis and management, disparities in access to preconception care and diabetes technologies remain major obstacles to optimal outcomes worldwide. We review the scientific discoveries and clinical advances that have shaped modern care and discuss the persistent challenges and future directions in the management of pregestational diabetes in pregnancy.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Drummond RF, Seif KE, Reece EA, et al. From peril to new reality: scientific advances transform pregestational diabetes in pregnancy care and outcomes. Am J Obstet Gynecol. 2026. PMID: 42447976. doi:10.1016/j.ajog.2026.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。